Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Proof of Concept Clinical Trial of the Combination Cediranib-Olaparib at the Time of Disease Progression on Olaparib in Ovarian Cancer

NCT02340611 is registered in ClinicalTrials.gov with University Health Network, Toronto as lead sponsor.

NCT NCT02340611
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02340611 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Proof of Concept Clinical Trial of the Combination Cediranib-Olaparib at the Time of Disease Progression on Olaparib in Ovarian Cancer
Lead sponsor
University Health Network, Toronto
Phase
Phase 2
Overall status
Completed
Start date
June 30, 2015
Completion date
June 30, 2018
Enrollment
4 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

ovarian cancer